Directed Immuno Nutrition by L-arginine for Critically Ill Patients
Status:
Completed
Trial end date:
2011-01-01
Target enrollment:
Participant gender:
Summary
The main objective of this proof-of-concept study is to demonstrate that the only
administration of L-arginine, based on a suspected deficit monitored by nasal nitric oxide
measurement, can improve immune functions in critically ill patients at high risk of
nosocomial infection.